학술논문

Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon Cancer
Original Article
Document Type
Academic Journal
Source
Digestive Diseases and Sciences. July 15, 2019, Vol. 64 Issue 7, p1857, 11 p.
Subject
Development and progression
Genetic aspects
Comparative analysis
Colon cancer -- Genetic aspects -- Development and progression
Tumor necrosis factor -- Genetic aspects -- Comparative analysis
Cancer genetics -- Development and progression -- Genetic aspects
Genetic research -- Comparative analysis -- Genetic aspects
Necrosis -- Development and progression -- Genetic aspects
Cancer research -- Comparative analysis -- Genetic aspects
Genes -- Comparative analysis -- Genetic aspects
Endothelium -- Comparative analysis -- Genetic aspects
Single nucleotide polymorphisms -- Genetic aspects -- Comparative analysis
Tumors -- Genetic aspects -- Development and progression
Oncology, Experimental -- Comparative analysis -- Genetic aspects
Cancer -- Genetic aspects -- Research
Language
English
ISSN
0163-2116
Abstract
Author(s): Tomasz Jerzy Slebioda [sup.1], Marcin Stanislawowski [sup.1], Marta Cyman [sup.1], Piotr Mieczyslaw Wierzbicki [sup.1], Dorota Zurawa-Janicka [sup.2], Jarek Kobiela [sup.3], Wojciech Makarewicz [sup.4], Marek Guzek [sup.5], Zbigniew Kmiec [sup.1] [...]
Background Tumor necrosis factor superfamily member 15 (TNFSF15) gene is involved in development of several cancers. It encodes two proteins: tumor necrosis factor ligand-related molecule 1A (TL1A) and vascular endothelial growth inhibitor 192 (VEGI-192). The main receptor for TL1A is death receptor 3 (DR3). Aims We investigated expression of TL1A, VEGI-192, and DR3 transcripts in different stages of colon cancer and compared them with survival of patients. We also aimed to reveal possible effects of microsatellite instability (MSI) and selected TNFSF15 single-nucleotide polymorphisms (SNPs) on expression of this gene. Methods Forty-five healthy individuals and 95 colon cancer patients were included in the study. Expression of VEGI-192, TL1A, and DR3 was measured by quantitative PCR. SNP and MSI analyses were performed on DNA isolated from normal or cancer tissue. Results Expression of VEGI-192 and TL1A was elevated in colon cancer, although the level of VEGI-192 decreased, while the level of TL1A increased with the progression of cancer. Patients with low expression of TL1A and/or high expression of VEGI-192 in tumor-transformed tissue showed longer survival. DR3 expression was decreased in the cancer, but it did not change with the tumor progression. Alleles T of rs6478108 and G of rs6478109 SNPs were associated with elevated expression of the TNFSF15 gene. There was no relation between the MSI status and TNFSF15 expression levels. Conclusions Expression of the TNFSF15 gene isoforms was associated with the progression of colon cancer. Levels of TL1A and VEGI-192 transcripts can be considered as independent prognostic factors for colon cancer.